Hybrid Biotech-Medtech Model

Definition

Framework that a company combining drug-like clinical trials with a device delivery mechanism has a cost and growth profile that shifts from biotech-style discovery spending to medtech-style organic expansion once the mechanism is established.

Cast within

No topic-region cast yet — this appears once Hybrid Biotech-Medtech Model's compiled claims are aligned into a topic region's argument tree.

Claims mentioning Hybrid Biotech-Medtech Model (3)

Your notes

Loading notes...